Search Results
ASH 2017 top picks: Phase III trials, antibody-drug conjugates and CAR T-cells
ASH Annual Meeting: CAR-T and Multiple Myeloma
Immunotherapy discussions at ASH 2017
New antibody-drug conjugates for lymphoma
Car T-Cell Therapy & Conjugated BCMA Monoclonal Antibodies
ASH 2017: IMWG Conference Series
ASPIRE trial for MM: updates from ASH 2017
Progress still being made in MM: highlights of ASH 2017
Paradigm-changing CAR T-cell therapy for multiple myeloma
ASH 2017 President’s meeting highlights
Dr. Andreadis on Antibody-Drug Conjugates in DLBCL
Prof. Sagar Lonial | ASH 2017 | Highlights of ASH in RRMM
